Focus Partners Wealth’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.17M Buy
200,770
+3,467
+2% +$80.3K 0.01% 945
2026
Q1
$4.06M Sell
197,303
-3,839
-2% -$86.5K ﹤0.01% 1011
2025
Q4
$4.77M Sell
201,142
-2,146
-1% -$52.2K 0.01% 962
2025
Q3
$5.06M Buy
203,288
+105,827
+109% +$2.28M 0.01% 742
2025
Q2
$2.24M Buy
+97,461
New +$2.26M ﹤0.01% 872
2024
Q2
Sell
-74,808
Closed -$1.47M 1259
2024
Q1
$1.47M Buy
74,808
+40,325
+117% +$852K 0.01% 533
2023
Q4
$794K Buy
+34,483
New +$772K 0.01% 490

Other funds holding PRVA

Focus Partners Wealth's PRVA Position: Q2 2026 in Review

Focus Partners Wealth increased its Privia Health (PRVA) stake by 1.8% in Q2 2026, buying an estimated $80.3K and bringing the position to 200,770 shares worth $5.17M. The position accounts for 0.01% of the portfolio, ranked #945.

Focus Partners Wealth first reported a position in PRVA in Q4 2023 and has held it in 7 quarters since. 302 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • Focus Partners Wealth held 200,770 shares of Privia Health worth $5.17M as of Q2 2026.
  • Focus Partners Wealth bought 3,467 Privia Health shares in Q2 2026, an estimated $80.3K.
  • Privia Health made up 0.01% of Focus Partners Wealth's portfolio in Q2 2026, its #945 holding.
  • Focus Partners Wealth first reported a position in Privia Health in Q4 2023 and has held it in 7 quarters since.
  • 302 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on Focus Partners Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.